Table 1 Psychotropic drugs and FDA labeled psychiatric uses in youth.*
From: Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring
Class, Subclass | Drug | Age Limits, yr. | Indication |
|---|---|---|---|
Stimulants | Â | Â | Â |
| Â | Amphetamines | 3+ | ADHD; Narcolepsy |
| Â | Methylphenidate | 6+ | ADHD; Narcolepsy |
| Â | Modafinil | 16+ | Narcolepsy |
Antidepressants | Â | Â | Â |
SSRI | Â | Â | Â |
| Â | Fluoxetine | 8+ | Depression |
| Â | Â | 7+ | OCD |
| Â | Fluvoxamine | 8+ | OCD |
| Â | Sertraline | 6+ | OCD |
TCA | Â | Â | Â |
| Â | Clomipramine | 10+ | OCD |
| Â | Doxepin | 12+ | Depression |
| Â | Impiramine | 6+ | Enuresis |
| Â | Â | 12+ | Depression |
Antipsychotics | Â | Â | Â |
Conventional | Â | Â | Â |
| Â | Chlorpromazine | 6 (mo)-12 | Severe Behavior Problems; Psychosis |
| Â | Haloperidol | 3+ | Tourette's Disorder; Psychosis; Severe Behavioral Disorders |
| Â | Thiothixene | 12+ | Psychosis |
| Â | Loxapine | 16+ | Psychosis |
| Â | Molindone | 12+ | Psychosis |
| Â | Fluphenazine | 12+ | Psychosis |
| Â | Trifluperazine | 12+ | Psychosis |
| Â | Perphenazine | 12+ | Schizophrenia |
| Â | Pimozide | 12+ | Tourette's Disorder |
|  | Prochlorperazine | 2–12 | Psychosis |
| Â | Thioridazine | 2+ | Schizophrenia |
Atypical | Â | Â | Â |
| Â | Aripiprazole | 13+ | Schizophrenia |
| Â | Â | 10+ | Acute and Mixed Mania |
| Â | Risperidone | 10+ | Acute and Mixed Mania; |
|  |  | 5–16 | Irritability in Autism |
| Â | Â | 13+ | Schizophrenia |
Miscellaneous | Â | Â | Â |
| Â | Atomoxetine | 6+ | ADHD |
| Â | Chlordiazepoxide | 6+ | Anxiety |
| Â | Clorazepate | 10+ | Anxiety |
| Â | Desmopressin Oral | 6+ | Enuresis |
| Â | Diazepam | 6 months + | Anxiety |
| Â | Flurazepam | 15+ | Insomnia |
| Â | Hydroxyzine | < 6 | Anxiety |
| Â | Â | > 6 | Sedation |
| Â | Lithium Carbonate | 12+ | Manic Episodes |
| Â | Promethazine | 2+ | Sedation |